News
HC Wainwright & Co. Reiterates Buy on Lisata Therapeutics, Maintains $15 Price Target
26 Apr 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Lisata Therapeutics, Maintains $15 Price Target
25 Apr 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Lisata Therapeutics, Maintains $15 Price Target
1 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Recap: Lisata Therapeutics Q4 Earnings
29 Feb 24
Earnings
Earnings Scheduled For February 29, 2024
29 Feb 24
Earnings
Lisata Therapeutics's Earnings Outlook
28 Feb 24
Earnings
Press releases
Lisata Therapeutics advances lead asset LSTA1 for treatment of advanced solid tumors
23 Apr 24
Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu's Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
23 Apr 24
Press Releases
Lisata Therapeutics to Participate in Upcoming April 2024 Industry and Investor Events
3 Apr 24
News, Press Releases